After losing Bristol Myers Squibb…
After losing Bristol Myers Squibb as a client, Cellares continues [...]
Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future
Novo Nordisk’s chief executive, Mike Doustdar, is a year into [...]
Novartis appears to have broken…
Novartis appears to have broken the curse of the BTK [...]
This podcast feature a fireside…
This podcast feature a fireside chat between Dr Ira Mellman, [...]
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
Rasonque, the new pancreatic cancer treatment from Revolution Medicines, illustrates [...]
Jazz Pharmaceuticals has added a…
Jazz Pharmaceuticals has added a second overall survival win to [...]
Late August has been rough for IV…
Late August has been rough for IV solution makers as [...]
After a surprise washout in a…
After a surprise washout in a recent phase 3 trial [...]
Walmart to Pay $50 Million to Settle Opioid Lawsuit, US Says
The resolution is part of an effort to hold retailers [...]
The FDA has approved Takeda’s…
The FDA has approved Takeda’s Mimrylo (rusfertide) for polycythemia vera, [...]